Beiersdorf sales
This article was originally published in The Rose Sheet
Executive Summary
Nivea generated $2.75 bil. (€1=$1.06) in 2002, fueling 7.2% gain in Beiersdorf's Cosmed division, German company announces in 1preliminary 2002 sales and earnings release Jan. 15. Cosmed division sales reached $3.35 bil., and earnings before interest and taxes increased approximately 13%, Beiersdorf says. Consolidated sales increased 4.4% to $5.02 bil., and after tax profit was $303.5 mil., an increase of approximately 23.7%. Endorsement of the financial statement by a supervisory board is scheduled for mid March, and Beiersdorf's annual press conference will be held April 2...
You may also be interested in...
Beiersdorf Goal For Nivea Includes 250 Market-Leading Positions By 2006
Beiersdorf's expansion plans for Nivea call for capturing 250 market-leading positions worldwide by 2006, the German firm said in its Feb. 5 1year-end sales release
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.